Literature DB >> 9723694

CD28 co-stimulation stabilizes the expression of the CD40 ligand on T cells.

C Johnson-Léger1, J Christensen, G G Klaus.   

Abstract

The ligand for CD40 (CD40L) is a protein which is expressed on CD4 T cells following their activation: CD40-CD40L interactions are absolutely required for the induction of T cell-dependent antibody responses, yet little is known about the mechanisms whereby CD40L+ primary T cells activate naive B cells, since the protein is only transiently expressed and is rapidly down-regulated following T cell-B cell contact. We show here, using a variety of assays, that co-stimulation of primary murine T cells via CD3 and CD28 stabilizes the expression of the CD40L protein. Firstly, T cells stimulated in this manner express higher levels of CD40L when activated in the presence of B cells, compared to CD3-activated T cells. Secondly, the CD40L expressed on CD28-co-stimulated T cells is more resistant to B cell-induced down-regulation. Finally, CD3/CD28-preactivated, rested T cells re-express higher levels of CD40L more rapidly following re-stimulation via CD3 than T cells preactivated via CD3 alone. CD3/CD28-preactivated T cells, but not CD3-activated cells, are competent to induce DNA synthesis in naive B cells, and this requires re-stimulation via CD3 and prolonged ligation of CD40. These data therefore reinforce the concept that naive T cells need to be activated initially by cognate interaction with B7-bearing antigen-presenting cells (such as dendritic cells), before becoming competent helper effector cells capable of driving B cells into proliferation via a CD40-dependent pathway.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9723694     DOI: 10.1093/intimm/10.8.1083

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  17 in total

1.  STAT3 Knockdown in B16 Melanoma by siRNA Lipopolyplexes Induces Bystander Immune Response In Vitro and In Vivo.

Authors:  Aws Alshamsan; Samar Hamdy; Azita Haddadi; John Samuel; Ayman O S El-Kadi; Hasan Uludağ; Afsaneh Lavasanifar
Journal:  Transl Oncol       Date:  2011-06-01       Impact factor: 4.243

2.  In vitro induction of immunoglobulin A (IgA)- and IgM-secreting plasma blasts by cholera toxin depends on T-cell help and is mediated by CD154 up-regulation and inhibition of gamma interferon synthesis.

Authors:  Sergio Arce; Hesham F Nawar; Gwendolin Muehlinghaus; Michael W Russell; Terry D Connell
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

3.  Protective role for interleukin-5 during chronic Toxoplasma gondii infection.

Authors:  Y Zhang; E Y Denkers
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 4.  Dendritic cells in viral pathogenesis: protective or defective?

Authors:  Gabriele Pollara; Antonia Kwan; Philippa J Newton; Matthew E Handley; Benjamin M Chain; David R Katz
Journal:  Int J Exp Pathol       Date:  2005-08       Impact factor: 1.925

Review 5.  The pharmacology of second-generation chimeric antigen receptors.

Authors:  Sjoukje J C van der Stegen; Mohamad Hamieh; Michel Sadelain
Journal:  Nat Rev Drug Discov       Date:  2015-07       Impact factor: 84.694

Review 6.  Post-transcriptional regulation in lymphocytes: the case of CD154.

Authors:  Stefano Vavassori; Lori R Covey
Journal:  RNA Biol       Date:  2009-07-29       Impact factor: 4.652

7.  The dinucleotide repeat polymorphism in the 3'UTR of the CD154 gene has a functional role on protein expression and is associated with systemic lupus erythematosus.

Authors:  M J Citores; I Rua-Figueroa; C Rodriguez-Gallego; A Durántez; M I García-Laorden; C Rodríguez-Lozano; J C Rodríguez-Pérez; J A Vargas; P Pérez-Aciego
Journal:  Ann Rheum Dis       Date:  2004-03       Impact factor: 19.103

8.  Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities.

Authors:  Fouad Eddahri; Sébastien Denanglaire; Fabrice Bureau; Rosanne Spolski; Warren J Leonard; Oberdan Leo; Fabienne Andris
Journal:  Blood       Date:  2008-11-19       Impact factor: 22.113

9.  CD28 and inducible costimulator (ICOS) signalling can sustain CD154 expression on activated T cells.

Authors:  Denise A Kaminski; Byung O Lee; Sheri M Eaton; Laura Haynes; Troy D Randall
Journal:  Immunology       Date:  2008-12-13       Impact factor: 7.397

10.  Direct inhibition of CD40L expression can contribute to the clinical efficacy of daclizumab independently of its effects on cell division and Th1/Th2 cytokine production.

Authors:  James T Snyder; Jijia Shen; Hooman Azmi; Jeannie Hou; Daniel H Fowler; Jack A Ragheb
Journal:  Blood       Date:  2007-03-07       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.